‘HIV vaccine research has long been hindered by a missing sense of urgency’
In 2010, William Schief, an immunologist at Scripps and executive director of vaccine design at IAVI’s Neutralizing Antibody Center, working with a group of researchers began to work with a class of broadly neutralising antibodies called VRC01, the first to be discovered by the NIH Vaccine Research Center. First, they...
Is HIV/Aids vaccine in sight? Covid success provides scientists with a ‘wisp of hope’
When virologist José Esparza began working with the World Health Organization to combat the AIDS epidemic in the 1980s, he and many of his colleagues were convinced that a vaccine would be the solution – and that it would come quickly. Their optimism rested on solid science: Researchers knew that...
